Medical Properties Trust, Inc. (NYSE:MPW) Director G Steven Dawson Purchases 7,476 Shares

Medical Properties Trust, Inc. (NYSE:MPW) Director G Steven Dawson bought 7,476 shares of the stock in a transaction on Thursday, August 8th. The shares were acquired at an average cost of $18.07 per share, for a total transaction of $135,091.32. Following the acquisition, the director now directly owns 76,302 shares in the company, valued at $1,378,777.14. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Shares of Medical Properties Trust stock traded down $0.09 during trading on Friday, hitting $18.11. The stock had a trading volume of 3,117,059 shares, compared to its average volume of 3,839,774. The stock has a market capitalization of $7.18 billion, a price-to-earnings ratio of 13.22, a price-to-earnings-growth ratio of 3.27 and a beta of 0.60. Medical Properties Trust, Inc. has a 12 month low of $13.98 and a 12 month high of $18.92. The company’s 50-day moving average price is $17.91. The company has a debt-to-equity ratio of 0.99, a quick ratio of 9.37 and a current ratio of 8.00.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings results on Thursday, August 1st. The real estate investment trust reported $0.31 earnings per share for the quarter, hitting the consensus estimate of $0.31. The firm had revenue of $192.55 million for the quarter, compared to analysts’ expectations of $186.11 million. Medical Properties Trust had a net margin of 129.20% and a return on equity of 6.84%. The business’s quarterly revenue was down 4.6% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.36 earnings per share. On average, sell-side analysts expect that Medical Properties Trust, Inc. will post 1.33 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which was paid on Thursday, July 11th. Stockholders of record on Thursday, June 13th were issued a $0.25 dividend. The ex-dividend date of this dividend was Wednesday, June 12th. This represents a $1.00 annualized dividend and a dividend yield of 5.52%. Medical Properties Trust’s payout ratio is currently 72.99%.

Several institutional investors have recently added to or reduced their stakes in MPW. Panagora Asset Management Inc. increased its stake in Medical Properties Trust by 1,670.8% in the second quarter. Panagora Asset Management Inc. now owns 1,461,703 shares of the real estate investment trust’s stock valued at $25,492,000 after acquiring an additional 1,379,158 shares during the last quarter. Russell Investments Group Ltd. boosted its position in Medical Properties Trust by 38.1% during the second quarter. Russell Investments Group Ltd. now owns 3,131,544 shares of the real estate investment trust’s stock valued at $54,569,000 after buying an additional 864,292 shares during the period. Prudential Financial Inc. boosted its position in Medical Properties Trust by 0.6% during the second quarter. Prudential Financial Inc. now owns 3,003,826 shares of the real estate investment trust’s stock valued at $52,387,000 after buying an additional 17,232 shares during the period. Teza Capital Management LLC purchased a new stake in Medical Properties Trust during the second quarter valued at about $260,000. Finally, Schroder Investment Management Group boosted its position in Medical Properties Trust by 9.7% during the second quarter. Schroder Investment Management Group now owns 117,809 shares of the real estate investment trust’s stock valued at $2,055,000 after buying an additional 10,427 shares during the period. 80.70% of the stock is currently owned by hedge funds and other institutional investors.

A number of equities research analysts have issued reports on the stock. ValuEngine cut shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Deutsche Bank raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a report on Monday, July 29th. SunTrust Banks raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating and boosted their target price for the company from $19.00 to $20.00 in a report on Tuesday, July 2nd. Stifel Nicolaus raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating and boosted their target price for the company from $18.00 to $19.00 in a report on Tuesday, July 23rd. Finally, Zacks Investment Research cut shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a report on Wednesday, July 17th. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have issued a buy rating to the stock. Medical Properties Trust currently has an average rating of “Buy” and a consensus price target of $18.69.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

Read More: Strangles

Insider Buying and Selling by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.